ClinicalTrials.Veeva

Menu

Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters

M

Murielle Surquin

Status

Completed

Conditions

Alzheimer Disease

Treatments

Other: Medical file data extraction

Study type

Observational

Funder types

Other

Identifiers

NCT03408041
CHUB-parameters Alzheimer

Details and patient eligibility

About

The early diagnosis of Alzheimer's disease is essential to enable patients to have access to the available treatments. However, there is a delay between the diagnosis and the onset of symptoms, which can range from 1 year to more than 5 years. In clinical practice, the hippocampal volume, measured by the Scheltens index, is currently used as a marker of the progression of the disease.

The purpose of this study is to determine whether the patient's sex, age and ethnicity can influence the delay in the expression of cognitive troubles reported by the family at the first medical consultation, as well as to determine if there is a correlation between the delay reported by the family and the Scheltens index.

Enrollment

129 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Alzheimer Disease patients admitted in the 'Memory Clinic' of the CHU Brugmann Hospital between 01-01-2010 and 31-01-2013. Diagnose according to the Dubois criteria

Exclusion criteria

None

Trial design

129 participants in 1 patient group

Alzheimer Disease
Description:
Alzheimer Disease patients admitted in the 'Memory Clinic' of the CHU Brugmann Hospital between 01-01-2010 and 31-01-2013. Diagnose according to the Dubois criteria
Treatment:
Other: Medical file data extraction

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems